Diabetes prevalence and diagnosis in US states: Analysis of health surveys

被引：97
作者：
Danaei G. [1 ,2 ]
Friedman A.B. [2 ]
Oza S. [2 ]
Murray C.J.L. [3 ]
Ezzati M. [1 ,2 ]
机构：
[1] Harvard School of Public Health, Boston, Massachusetts
[2] Initiative for Global Health, Harvard University, Cambridge, Massachusetts
[3] Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington
来源：
Population Health Metrics | / 7卷 / 1期
关键词：
Fasting Plasma Glucose; Diabetes Prevalence; Behavioral Risk Factor Surveillance System; Diabetes Diagnosis; Undiagnosed Diabetes;
D O I：
10.1186/1478-7954-7-16
中图分类号：
学科分类号：
摘要：
Background: Current US surveillance data provide estimates of diabetes using laboratory tests at the national level as well as self-reported data at the state level. Self-reported diabetes prevalence may be biased because respondents may not be aware of their risk status. Our objective was to estimate the prevalence of diagnosed and undiagnosed diabetes by state. Methods: We estimated undiagnosed diabetes prevalence as a function of a set of health system and sociodemographic variables using a logistic regression in the National Health and Nutrition Examination Survey (2003-2006). We applied this relationship to identical variables from the Behavioral Risk Factor Surveillance System (2003-2007) to estimate state-level prevalence of undiagnosed diabetes by age group and sex. We assumed that those who report being diagnosed with diabetes in both surveys are truly diabetic. Results: The prevalence of diabetes in the U.S. was 13.7% among men and 11.7% among women ≥ 30 years. Age-standardized diabetes prevalence was highest in Mississippi, West Virginia, Louisiana, Texas, South Carolina, Alabama, and Georgia (15.8 to 16.6% for men and 12.4 to 14.8% for women). Vermont, Minnesota, Montana, and Colorado had the lowest prevalence (11.0 to 12.2% for men and 7.3 to 8.4% for women). Men in all states had higher diabetes prevalence than women. The absolute prevalence of undiagnosed diabetes, as a percent of total population, was highest in New Mexico, Texas, Florida, and California (3.5 to 3.7 percentage points) and lowest in Montana, Oklahoma, Oregon, Alaska, Vermont, Utah, Washington, and Hawaii (2.1 to 3 percentage points). Among those with no established diabetes diagnosis, being obese, being Hispanic, not having insurance and being ≥ 60 years old were significantly associated with a higher risk of having undiagnosed diabetes. Conclusion: Diabetes prevalence is highest in the Southern and Appalachian states and lowest in the Midwest and the Northeast. Better diabetes diagnosis is needed in a number of states. © 2009 Danaei et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 20 条
[1]  
Murray C.J., Dias R.H., Kulkarni S.C., Lozano R., Stevens G.A., Ezzati M., Improving the comparability of diabetes mortality statistics in the U.S. and Mexico, Diabetes Care, 31, pp. 451-458, (2008)
[2]  
Ezzati M., Martin H., Skjold S., Vander H.S., Murray C.J., Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys, J R Soc Med, 99, pp. 250-257, (2006)
[3]  
National Health and Nutrition Examination Survey data sets and related documentation (Survey Questionnaire, Examination and Laboratory Protocols, 1988-1994 and 1999-2002), (2002)
[4]  
Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., Byrd-Holt D.D., Li C., Williams D.E., Gregg E.W., Bainbridge K.E., Saydah S.H., Geiss L.S., Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006, Diabetes Care, 32, pp. 287-294, (2009)
[5]  
Nelson D.E., Holtzman D., Bolen J., Stanwyck C.A., Mack K.A., Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS), Soz Praventivmed, 46, SUPPL. 1, (2001)
[6]  
Remington P.L., Smith M.Y., Williamson D.F., Anda R.F., Gentry E.M., Hogelin G.C., Design, characteristics, and usefulness of state-based behavioral risk factor surveillance: 1981-87, Public Health Rep, 103, pp. 366-375, (1988)
[7]  
Screening for type 2 diabetes mellitus in adults: recommendations and rationale, Am J Nurs, 104, pp. 83-90, (2004)
[8]  
Danaei G., Lawes C.M., Vander H.S., Murray C.J., Ezzati M., Global and regional mortality from ischaemic heart disease and stroke attributable to higher-thanoptimum blood glucose concentration: comparative risk assessment, Lancet, 368, pp. 1651-1659, (2006)
[9]  
Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., Willett W.C., Diet, lifestyle, and the risk of type 2 diabetes mellitus in women, N Engl J Med, 345, pp. 790-797, (2001)
[10]  
Trivedi A.N., Zaslavsky A.M., Schneider E.C., Ayanian J.Z., Trends in the quality of care and racial disparities in Medicare managed care, N Engl J Med, 353, pp. 692-700, (2005)
12